Woman during interview of the progress paradox

The Progress Paradox

The second episode of the series published today looks at the paradox in breast cancer where despite the substantial advancements in treatments over the past 20 years, breast cancer patients still face very different outcomes depending on where they live.  Survival rates for breast cancer patients in Europe vary steeply from 60% to over 90% depending on a country.
In the documentary breast cancer-advocates and experts discuss without editorial control by Roche the seriousness of the challenge and what is needed to ensure that the needs of breast cancer patients will be met in the years to come. 

Adverse event reporting

This digital dashboard is not intended to report an adverse event. For the purpose of reporting an adverse event about a Roche medicine, please either contact your local Health Authority or find contact details for the Roche Pharmacovigilance department pertaining to your location here. For any non-Roche medicine, please contact either your local Health Authority or your medicine manufacturer's local affiliate office.